NYSE - Delayed Quote USD

Doximity, Inc. (DOCS)

23.59 -0.32 (-1.34%)
At close: April 25 at 4:00 PM EDT
Loading Chart for DOCS
DELL
  • Previous Close 23.91
  • Open 23.82
  • Bid 21.00 x 800
  • Ask --
  • Day's Range 23.26 - 23.88
  • 52 Week Range 19.71 - 36.92
  • Volume 2,178,537
  • Avg. Volume 1,681,900
  • Market Cap (intraday) 4.401B
  • Beta (5Y Monthly) 1.17
  • PE Ratio (TTM) 35.21
  • EPS (TTM) 0.67
  • Earnings Date May 16, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 29.69

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

www.doximity.com

977

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DOCS

Performance Overview: DOCS

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DOCS
15.87%
S&P 500
5.84%

1-Year Return

DOCS
35.25%
S&P 500
22.03%

3-Year Return

DOCS
--
S&P 500
18.33%

5-Year Return

DOCS
--
S&P 500
18.33%

Compare To: DOCS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCS

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    4.40B

  • Enterprise Value

    3.71B

  • Trailing P/E

    35.21

  • Forward P/E

    31.45

  • PEG Ratio (5yr expected)

    2.71

  • Price/Sales (ttm)

    10.51

  • Price/Book (mrq)

    5.09

  • Enterprise Value/Revenue

    7.91

  • Enterprise Value/EBITDA

    21.39

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    29.39%

  • Return on Assets (ttm)

    9.91%

  • Return on Equity (ttm)

    15.34%

  • Revenue (ttm)

    468.33M

  • Net Income Avi to Common (ttm)

    137.63M

  • Diluted EPS (ttm)

    0.67

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    710.24M

  • Total Debt/Equity (mrq)

    1.74%

  • Levered Free Cash Flow (ttm)

    133.75M

Research Analysis: DOCS

Analyst Price Targets

24.00
29.69 Average
23.59 Current
35.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: DOCS

Fair Value

23.59 Current
 

Dividend Score

0 Low
DOCS
Sector Avg.
100 High
 

Hiring Score

0 Low
DOCS
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
DOCS
Sector Avg.
100 High
 

Research Reports: DOCS

  • DOCS: What does Argus have to say about DOCS?

    DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $26.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.

    Rating
    Price Target
     
  • DOCS: Lowering target price to $26.00

    DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $26.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • DOCS: Raising target price to $28.00

    DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $28.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • DOCS: Lowering target price to $27.00

    DOXIMITY INC-CLASS A has an Investment Rating of HOLD; a target price of $27.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     

People Also Watch